Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

58
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
04/24/2015 04/27/2015 04/28/2015 04/29/2015 04/30/2015 Date
105.15(c) 106.1(c) 101.4(c) 95.95(c) 96.79(c) Last
361 468 383 779 921 043 956 103 743 834 Volume
+1.20% +0.90% -4.43% -5.37% +0.88% Change
More quotes
Financials (€)
Sales 2015 12 969 M
EBIT 2015 3 012 M
Net income 2015 1 375 M
Debt 2015 9 155 M
Yield 2015 1,12%
Sales 2016 14 107 M
EBIT 2016 3 329 M
Net income 2016 1 587 M
Debt 2016 9 866 M
Yield 2016 1,24%
PER 2015 28,98
PER 2016 25,13
EV / Sales 2015 1,66x
EV / Sales 2016 1,58x
Capitalization 12 430 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through four divisions: Merck Serono, Consumer Health, Performance Materials & Merck Millipore.The Merck Serono division is biopharmaceutical division which markets both chemical and... 
Sector
Pharmaceuticals
Calendar
05/19Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
05/01 MERCK KGAA : EMD Millipore Assigned Patent
04/30 MERCK KGAA : Paul T. Anastas Awarded Emanuel Merck Lectureship 2015
04/30 MERCK KGAA : Threshold Pharmaceuticals Reports First Quarter 2015 Financial and ..
04/28DJPfizer, Merck and Bristol-Myers Squibb Report Solid Results
04/28 MERCK KGAA : Release according to Article 26, Section 1 of the WpHG with the obj..
04/27 MERCK KGAA : Millipore Introduces Magna ChIRP™ RNA Interactome Kits for th..
04/25 MERCK KGAA : Wins German Innovation Award with Liquid Crystals
04/24 MERCK KGAA : "Merck More Than A Mother " a new initiative in partnership with Na..
More news
Sector news : Specialty & Advanced Pharmaceuticals
05/04 UCB : ex-dividend day for annual dividend
05/03DJCostco Accuses J&J Vision Care Unit of Price Fixing
05/03 TEVA PHARMACEUTICAL : What does Mylan really think it's worth?
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
04/20 Merck KGaA and Pfizer's Phase 3 avelumab study in lung cancer underway
03/19 MERCK : Why Is Sigma-Aldrich's Deal With Roche Positive For Investors?
03/02 Investors Are Best To Avoid The iShares Nasdaq Biotechnology ETF (IBB)
03/01 Some Companies Are More Wonderful Than Others
02/27 SEEKING ALPHA'S BIOTECH WEEKLY : Achillion Overdone, Sanofi's Toujeo A Go, And M..


Comments 
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF